Medicaid
The CMS released April 22 a final rule focused on ensuring access to services for Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries in managed care delivery systems.
The CMS released April 22 a final rule focused on ensuring access to services for Medicaid beneficiaries in fee-for-service delivery systems in keeping with the Administration’s objectives to improve access for Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries.
The AHA appreciates that CMS acknowledges the critical role hospitals play in state Medicaid financing and the importance of supplemental payments to sustain beneficiary access to care in light of low Medicaid base payment rates, including rates paid through managed care organizations. I
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program demonstration to add health-related social needs services; expand Marketplace subsidies and cost-sharing assistance; provide pre-release services to…
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll released April 12 by the Kaiser Family Foundation.
The Centers for Medicare & Medicaid Services (CMS) March 27 issued a final rule designed to streamline the eligibility and enrollment process for Medicaid and the Children’s Health Insurance Program (CHIP). This proposed rule is the continuation of efforts by CMS to improve access and…
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost Medicaid or Children’s Health Insurance Program eligibility following the end of the COVID-19 public health emergency continuous coverage period.
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers impacted by the Change Healthcare cyberattack.
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies for sickle cell disease to apply through May 1 to participate in the Cell and Gene Therapy Access Model.
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains certain health care provisions of interest to hospitals. The Senate is expected to consider the legislation later this week.